A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

Clinical trial NCT00069121 · COMPLETED

Trial details

NCT number: NCT00069121
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2003-04-18
Primary completion: 2011-04-21
Enrollment: 1886

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.